Why the study?
Do heparin and glycosaminoglycans prevent the progression of glomerular disease?
Population
Patients with glomerular disease and experimental animal models of nephropathy
Design
Review
Authors
Loading...
Supports glycosaminoglycan trials in glomerular disease; leaves open any clinical use pending human data.
Do heparin and glycosaminoglycans prevent the progression of glomerular disease?
Heparin and glycosaminoglycans, independent of their anticoagulant activity, show promise in preventing the progression of glomerular disease in experimental models.
Gambaro et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: